Expertise in
4
conditions

Maeva Guillaume

France
Expertise in
4
conditions
Expertise in
4
conditions
OverviewLocationsClinical Research

Overview

Maeva Guillaume practices in Toulouse, France. Guillaume is highly rated in 4 conditions, according to our data. Her top areas of expertise are Non-Alcoholic Fatty Liver Disease, Cirrhosis, Portal Hypertension, Oophorectomy, and Hormone Replacement Therapy (HRT).

Her clinical research consists of co-authoring 38 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Toulouse, France
Other Locations
Alfortville, France
Rouen, France
CHU
Caen, France
1 Avenue De L'Hôpital, BP 90074, Pringy, 74374, France
Clinique De Médecine Interne Dr Bosseray, BP 217, 38043 Grenoble Cedex 9, Grenoble, 38043, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples
Evaluation of the Involvement of the Intestinal Microbiota and Choline Deficiency in the Severity of Chronic Liver Disease Explored by Analyzing Collection of Biological Samples
Enrollment Status: Completed
Publish Date: July 28, 2021
Using MRI for a Non-invasive Evaluation of Portal Pressure
Using MRI for a Non-invasive Evaluation of Portal Pressure
Enrollment Status: Terminated
Publish Date: August 21, 2019
Intervention Type: Procedure
Study Phase: Not Applicable
View 3 Less Clinical Trials

38 Total Publications

Allergens grouping names on packaging: Are the substances similar enough to ensure safety? The worst case scenarios question this.
Allergens grouping names on packaging: Are the substances similar enough to ensure safety? The worst case scenarios question this.
Journal: International journal of cosmetic science
Published: April 09, 2024

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this expert for later?
Sign Up
Looking for the best expert for you?
Start Here
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile